Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer (NSCLC) - the ...

Developments in artificial intelligence (AI) can help clinicians to diagnose thoracic conditions that may be miss on first glance.

Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response (MPR) rates ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

Mount Sinai Medical Center proudly announces the appointment of Dr. Eric S. Weiss, MD, MPH, as President of Cardiovascular & Thoracic Surgery (CVTS) and joining Dr. Steve Xydas as Co-Director of Valve ...

Patient-reported outcomes collected through an electronic health record-integrated symptom management program did not ...

Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf Coast to use the technology ...